Page last updated: 2024-08-21

podophyllotoxin and Multiple Sclerosis

podophyllotoxin has been researched along with Multiple Sclerosis in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (25.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Martin, R; Schippling, S	1
Bosi, A; Bruzzi, P; Di Bartolomeo, P; Donelli, A; Filippi, M; Gualandi, F; Guerrasio, A; La Nasa, G; Mancardi, GL; Marmont, AM; Murialdo, A; Pagliai, F; Papineschi, F; Saccardi, R; Scappini, B; Solari, A	1
Dong, HQ; Ji, BX; Lu, CY; Lu, DP; Su, L; Wan, SG; Xu, J; Yu, YY	1
Danielczyk, W	1

Reviews

1 review(s) available for podophyllotoxin and Multiple Sclerosis

Article	Year
[Stem cell therapy in multiple sclerosis: a clinical update]. Zeitschrift fur Rheumatologie, 2009, Volume: 68, Issue:3 Topics: Animals; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Carmustine; Central Nervous System; Clinical Trials, Phase II as Topic; Controlled Clinical Trials as Topic; Cytarabine; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Melphalan; Mitoxantrone; Multicenter Studies as Topic; Multiple Sclerosis; Podophyllotoxin; Risk Assessment; Survival Rate; Treatment Outcome	2009

Article

Year

[Stem cell therapy in multiple sclerosis: a clinical update].

Zeitschrift fur Rheumatologie, 2009, Volume: 68, Issue:3

Topics: Animals; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Carmustine; Central Nervous System; Clinical Trials, Phase II as Topic; Controlled Clinical Trials as Topic; Cytarabine; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Melphalan; Mitoxantrone; Multicenter Studies as Topic; Multiple Sclerosis; Podophyllotoxin; Risk Assessment; Survival Rate; Treatment Outcome

2009

Other Studies

3 other study(ies) available for podophyllotoxin and Multiple Sclerosis

Article	Year
Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. Blood, 2005, Mar-15, Volume: 105, Issue:6 Topics: Adult; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Female; Follow-Up Studies; Hematopoietic Stem Cell Mobilization; Humans; Male; Melphalan; Middle Aged; Multiple Sclerosis; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Quality of Life; Radiography; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome	2005
Autologous peripheral blood stem cell transplantation for severe multiple sclerosis. International journal of hematology, 2006, Volume: 84, Issue:3 Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Diarrhea; Disease-Free Survival; Female; Hematopoietic Stem Cell Mobilization; Humans; Liver Diseases; Lymphocyte Depletion; Male; Melphalan; Middle Aged; Mucositis; Multiple Sclerosis; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous	2006
[Immunosuppressive agents in multiple sclerosis. Preliminary trials with Proresid]. Wiener medizinische Wochenschrift (1946), 1968, Nov-02, Volume: 118, Issue:44 Topics: Adult; Autoimmune Diseases; Electroencephalography; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Multiple Sclerosis; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum	1968